NHS England (NHSE) recently launched a three-month public consultation on changes made to a number of its specialised services policies. These policies have already been subject to stakeholder engagement and comment, however, they are now consulting on the final documents. Consultation is open until 17th September 2014.
To view the documents and find out how you can contribute your views, please visit the NHSE website.
The list open for consultation are:
- Bortezomib for the Treatment of Refractory Antibody Mediated Rejection Post Kidney Transplant A07/P/b
- Eculizamab for the Treatment of Refractory Antibody Mediated Rejection Post Kidney Transplant A07/P/c
- Non Invasively Lengthened Spinal Rods for Scoliosis D14/P/a
- Dolutegravir for the Treatment of HIV- 1 in Adults and Adolescents B06/P/b